| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.8M | +2.1% | +4794.7% |
| R&D Expense | $2.3M | +0.9% | -54.8% |
| SG&A Expense | $1.7M | +3.1% | -49.9% |
| Operating Income | -$4.1M | -224.7% | +52.5% |
| Net Income | -$4.0M | -333.0% | +53.3% |
| EPS (Basic) | -$0.34 | -209.1% | +96.1% |
| EPS (Diluted) | -$0.34 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $2.0M | +50.5% | -6.1% |
| Current Assets | $9.6M | -37.4% | +7.9% |
| Total Assets | $12.4M | -20.3% | +39.2% |
| Current Liabilities | $7.9M | +7.3% | -5.5% |
| Total Liabilities | $7.9M | +7.3% | -28.0% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$15.4M | — | — |
| Investing Cash Flow | -$2.6M | — | — |
| Financing Cash Flow | $3.0M | — | — |
| -209.1% |
| +96.1% |
| $4.5M |
| -45.0% |
| +323.6% |